Shanghai, China

Chunchun Zhang


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):

Title: Chunchun Zhang: Innovator in Quinazoline Derivatives

Introduction

Chunchun Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his work on quinazoline derivatives. His innovative approach has led to advancements in anti-tumor activity, showcasing his commitment to improving healthcare.

Latest Patents

Chunchun Zhang holds a patent for a quinazoline derivative, which includes a preparation method, intermediate, composition, and application. The patent, titled "Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof," describes a quinazoline derivative represented by Formula (I) and its pharmaceutical acceptable salts. This invention also covers enantiomers, non-enantiomers, tautomers, racemates, solvates, metabolic precursors, and prodrugs. The quinazoline derivative is noted for its improved anti-tumor activity, making it a valuable asset in cancer treatment.

Career Highlights

Throughout his career, Chunchun Zhang has worked with prominent organizations, including Shanghai Pharmaceuticals Holdings Co., Ltd. and Zhejiang University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Chunchun Zhang has collaborated with notable colleagues such as Guangxin Xia and Jingkang Shen. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Chunchun Zhang's work in the field of quinazoline derivatives exemplifies his dedication to innovation and improving cancer treatment. His contributions have the potential to make a significant impact on the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…